Journal
JOURNAL OF SEPARATION SCIENCE
Volume 42, Issue 1, Pages 130-213Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/jssc.201801074
Keywords
biopharmaceutical drugs; glycoproteomics; hydrophilic interaction chromatography; therapeutic peptides
Categories
Funding
- JSPS KAKENHI [17K05900]
- Grants-in-Aid for Scientific Research [17K05900] Funding Source: KAKEN
Ask authors/readers for more resources
Applications of hydrophilic interaction chromatography for the analysis of biopharmaceutical drugs, i. e., glycosylated proteins represented by monoclonal antibodies are discussed in the manner of glycoproteomics. They can be analyzed using hydrophilic interaction chromatography in five different stages as (1) their intact forms, (2) their subunits, (3) N-and O-glycopeptides digested by proteases, (4) N-and O-glycans released from the glycoproteins or glycopeptides, and (5) monosaccharides. Hydrophilic interaction chromatography is a more useful tool in the order of (1) to (5). At the stages (4) and (5), quantitation of glycans and saccharides are also reported. Hydrophilic interaction chromatography is employed not only for analytical uses, but also pretreatment items as solid phase extraction, followed by reversed-phase liquid chromatography separations. Comprehensive search results of these application of hydrophilic interaction chromatography are summarized in tables to show what kind of hydrophilic interaction chromatography columns are suitable for each step of analysis. Relationship of favored and less favored hydrophilic interaction chromatography columns and their separation characteristics such as hydrophilicity, and selectivity for structural difference, is also discussed. Analysis of the therapeutic peptides (not glycosylated) using hydrophilic interaction chromatography is summarized, too.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available